Impact of a Structured Therapeutic Education Session on the Practice of Adapted Physical Activity in Chronic Inflammatory Bowel Diseases

NCT07305454 | Recruiting

• 2 other identifiers: RC31/25/0588ID-RCB
• Study Type: observational
• Target: 71
• Locations: 1 country
• Sites: 1

Brief Summary

Chronic inflammatory bowel diseases (IBD; including Crohn's disease and ulcerative colitis) significantly impact patients' quality of life. Among non-pharmacological therapies, adapted physical activity (APA) has demonstrated its beneficial impact, particularly on fatigue, anxiety, digestive symptoms, and the overall quality of life of patients with IBD. The real-world implementation of APA remains insufficient, primarily due to limited patient adherence to this prescription. Patient therapeutic education (PTE) represents a potentially powerful lever for promoting engagement in APA by addressing barriers related to a lack of awareness (fear of symptom worsening) and lack of motivation. No dedicated study has specifically evaluated the effect of targeted PTE sessions on adherence to physical activity in IBD. The objective of the present feasibility study will be to determine whether a single therapeutic education session focused on the digestive and systemic benefits of APA has an impact on the rate of physical activity practice in the medium term among patients with IBD in clinical remission for at least 3 months.

Conditions

Chronic Inflammatory Bowel Disease

Keywords

crohn disease; ulcerative colitis; physical activity

Outcome Measures

Primary Outcomes (1)

• Effectiveness of therapeutic education intervention on physical activity practice

  Measure the amount of metabolic equivalent or MET/Week (Metabolic Equivalent Task) at 12 months, based on the short-IPAQ questionnaire assessing physical activities reported by the patient over the last 7 days.

  12 months after the inclusion

Secondary Outcomes (8)

• study the impact on quality of life at 6 months

  6 months after the inclusion

• Study the impact on quality of life in 12 months

  12 months after the inclusion

• study the impact on fatigue reported at 6 months

  6 months after the inclusion

• study the impact on fatigue reported at 12 months

  12 months after the inclusion

• study the correlation between increased overall muscle strength and improved quality of life

  12 months after the inclusion

Study Arms (1)

patients with chronic inflammatory bowel disease

patients with chronic inflammatory bowel disease in clinical remission

Diagnostic Test: Inflammatory Bowek Disk Questionnaires; Other: Short-International Physical Activity Questionnaries

Interventions

Inflammatory Bowek Disk Questionnaires DIAGNOSTIC_TEST

Patients will be asked to complete the questionnaires regarding bowel inflammation at enrollment, 6 months later, and 12 months later.

patients with chronic inflammatory bowel disease

Short-International Physical Activity Questionnaries OTHER

Patients will be asked to complete the physical activity questionnaire 6 months later and 12 months later.

patients with chronic inflammatory bowel disease

Eligibility Criteria

• Age: 18 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

patients with chronic inflammatory bowel disease in clinical remission (Crohn's disease or ulcerative colitis)

You may qualify if:

• Confirmed diagnosis of Inflammatory Bowel Disease
• Crohn's disease in clinical remission (defined by a Harvey Bradshaw Index ≤ 5) or ulcerative colitis in clinical remission (defined by a Mayo score \< 3 and no subscore \> 1) for at least 3 months
• Social Security coverage

You may not qualify if:

• Pregnant or breastfeeding woman
• Patient under legal guardianship
• Cardiovascular or rheumatic conditions contraindicating participation in sports
• Neurological conditions with residual deficits contraindicating participation in sports
• Refusal or inability to consent to participation

Sponsors & Collaborators

• University Hospital, Toulouse: lead

Study Sites (1)

Service de Gastro-Entérologie, CHU Toulouse, Hôpital Rangueil, 1 avenue Jean Poulhès

Toulouse, 31059, France

RECRUITING

MeSH Terms

Conditions

Crohn Disease; Colitis, Ulcerative; Motor Activity

Condition Hierarchy (Ancestors)

Inflammatory Bowel Diseases; Gastroenteritis; Gastrointestinal Diseases; Digestive System Diseases; Intestinal Diseases; Colitis; Colonic Diseases; Behavior

Central Study Contacts

Cyrielle GILLETTA, MD

CONTACT

05 61 31 22 31; gilletta.c@chu-toulouse.fr

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Target Duration: 12 Months
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 12, 2025
• First Posted: December 26, 2025
• Study Start: February 10, 2026
• Primary Completion (Estimated): August 10, 2027
• Study Completion (Estimated): February 10, 2029
• Last Updated: February 13, 2026

Record last verified: 2026-02

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)